Search results
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 8 hours agoThe FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a...
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 3 days agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 13 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 6 hours agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 9 hours agoThe FDA has informed Moderna that it is working to conclude...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 23 hours agoAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021.
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 13 hours agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 2 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 1 day agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...